The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 4
- 4 new
- Median first-year cost
- $306,062
- $1,245,915 in all
- Institutions
- 4
- 4 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
0
0
0
0
4
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- CLOVERLEAF BIO, INC.1
- FERRIC CONTRAST, INC.1
- SPIKE NEURO LLC1
- VIVERE ONCOTHERAPIES, INC.1
Most frequent study sections
- Special Emphasis Panel (ZCA1 TCRB-Q (J2))4
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2025 | Developing engineered inhibitors of tRNA modifying enzymes1R42CA290914-01A1 | Draycott, Austin Stratton | CLOVERLEAF BIO, INC., CT | First-year cost $399,966 | Study section ZCA1 |
| FY2025 | Translation of Evolved Oncolytic Virotherapy Product for Colorectal Cancer Treatment1R41CA301762-01 | Schieferecke, Adam J | VIVERE ONCOTHERAPIES, INC., CA | First-year cost $306,871 | Study section ZCA1 |
| FY2025 | MRI contrast agents based on iron as alternatives to gadolinium agents.1R41CA301774-01 | Snyder, Eric M | FERRIC CONTRAST, INC., NY | First-year cost $305,253 | Study section ZCA1 |
| FY2025 | The development of a flexible carbon fiber penetrating nerve cuff and cortical array for neural recording, stimulation, and neurochemical detection1R41MH141906-01 | Boyer, Aidan | SPIKE NEURO LLC, MI | First-year cost $233,825 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-22-0.3.11. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.